Instituto Dante Pazzanese de Cardiologia
São Paulo 04012-909
3 studies enrolling now · 13 studies all time
What they study most
Acute Coronary Syndrome, Atrial Fibrillation, Covid19, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction, Stroke, Symptomatic Hypertrophic Cardiomyopathy (HCM), Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy, Transthyretin Amyloidosis, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Transthyretin Gene Mutations, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Studies at this site
- MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) — Recruiting now
- A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) — Running, not enrolling
- A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
- A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
- The Merit WRAPSODY AV Access Efficacy Study (WAVE) — Completed
- An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) — Enrolling by invitation
- Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation
- CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
- Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE — Completed
- Transthyretin Amyloidosis Outcome Survey (THAOS) — Completed
- GLORIA-AF Registry Program - Second and Third Phases — Completed
- Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
- A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI — Completed